505 results on '"Seibold, James R."'
Search Results
2. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
3. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis
4. Reliability, validity and responsiveness to change of the Saint George’s Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis
5. Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
6. Correlates and Responsiveness to Change of Measures of Skin and Musculoskeletal Disease in Early Diffuse Systemic Sclerosis
7. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
8. Clinical Outcome Measures in Raynaud’s Phenomenon
9. P149 An Exploratory Trial Assessing Finger Perfusion, Raynaud’s Condition Score and Safety, Following a Single Dose of CAM2043 (Treprostinil Subcutaneous Depot) in Patients with Raynaud's Phenomenon Secondary to Systemic Sclerosis
10. Rapidly Progressive Skin Disease in a Patient with Diffuse Systemic Sclerosis
11. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
12. PAH in CTD – Clinical Trials Criteria and Performance
13. Scleroderma
14. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria
15. Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort
16. Systemic Sclerosis : C. Treatment and Assessment
17. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
18. Nintedanib in patients with autoimmune disease-related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial
19. Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials
20. Digital ulcers in SSc treated with oral treprostinil: a randomized, double-blind, placebo-controlled study with open-label follow-up
21. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
22. Nintedanib in patients with autoimmune disease-related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial
23. Single-Factor Scoring Validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in Patients with Systemic Sclerosis and Comparison with Early Rheumatoid Arthritis Patients
24. Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence
25. Progress and priorities in systemic sclerosis: the next 10 years – report from the World Scleroderma Foundation
26. Clinical Outcome Measures in Raynaud’s Phenomenon
27. Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
28. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
29. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis
30. Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial.
31. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
32. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
33. Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
34. Cyclophosphamide versus placebo in scleroderma lung disease
35. Survival in Systemic Sclerosis With Pulmonary Arterial Hypertension Has Not Improved in the Modern Era
36. PAH in CTD – Clinical Trials Criteria and Performance
37. Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts
38. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group
39. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis
40. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
41. Response to: ‘Correspondence on ‘Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial’’ by Bredemeier
42. STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis–associated Interstitial Lung Disease
43. Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
44. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis
45. A higher degree of criticism about the effectiveness of bosentan for digital ulcers in scleroderma patients, as for interstitial disease, is also necessary: Comment on the article by Seibold et al
46. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
47. Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group
48. Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
49. Editorial
50. Reliability and Validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.